AP
ENZY

Alydar Partners’s Enzymotec Ltd ENZY Stock Holding History

Alydar Partners’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$449K Buy
+62,300
New +$441K 0.24% 54
2014
Q2 		– Sell
-311,350
Closed -$6.86M – 144
2014
Q1 		$6.86M Buy
311,350
+221,350
+246% +$5.87M 0.68% 39
2013
Q4 		$2.43M Buy
+90,000
New +$2.14M 0.25% 77

Other funds holding ENZY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Alydar Partners's ENZY Position: Q1 2015 in Review

Alydar Partners opened a new position in Enzymotec Ltd (ENZY) in Q1 2015: 62,300 shares worth $449K. The stake represents 0.24% of the portfolio and ranks #54 among its holdings. This is a return to the name: Alydar Partners previously reported a position in ENZY as recently as Q1 2014.

Alydar Partners first reported a position in ENZY in Q4 2013 and has held it in 3 quarters since. The position peaked at $6.86M in Q1 2014. 20 funds tracked by Wall St. Rank hold ENZY as of Q1 2015.

  • Alydar Partners held 62,300 shares of Enzymotec Ltd worth $449K as of Q1 2015.
  • Enzymotec Ltd was a new Alydar Partners position in Q1 2015.
  • Enzymotec Ltd made up 0.24% of Alydar Partners's portfolio in Q1 2015, its #54 holding.
  • Alydar Partners first reported a position in Enzymotec Ltd in Q4 2013 and has held it in 3 quarters since.
  • Alydar Partners's Enzymotec Ltd position peaked at $6.86M in Q1 2014.
  • 20 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2015.

Based on Alydar Partners's 13F filing for Q1 2015, filed 15 May 2015.